Growing community of inventors

Fujian, China

Hongxi Lai

Average Co-Inventor Count = 4.00

ph-index = 1

The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.

Forward Citations = 3

Hongxi LaiRongzhen Xu (11 patents)Hongxi LaiFrank Rong (11 patents)Hongxi LaiFuwen Xie (11 patents)Hongxi LaiHongxi Lai (11 patents)Rongzhen XuRongzhen Xu (15 patents)Frank RongFrank Rong (12 patents)Fuwen XieFuwen Xie (12 patents)
..
Inventor’s number of patents
..
Strength of working relationships

Company Filing History:

1. Hangzhou Bensheng Pharmaceutical Co., Ltd. (10 from 11 patents)

2. Hangzhou Bensheng Pharmaceuticals Co., Ltd. (1 from 1 patent)

3. Bensen Pharmaceutical (shanghai) Corp. Ltd. (0 patent)


11 patents:

1. 9902736 - 1-oxo/acylation-14-acylated oridonin derivative, preparation method therefor and application thereof

2. 9771343 - 2-alkyl-or-aryl-substituted tanshinone derivatives, and preparation method and application thereof

3. 9676789 - Aminated derivative of homoharringtonine, preparation method therefor, and application thereof

4. 9428519 - Acylated derivative of homoharringtonine, preparation method therefor, and application thereof

5. 9328083 - 2-aminated methylene or 2-esterified methylene tanshinone derivatives, and preparation method and application thereof

6. 9328122 - 7-substituted Hanfangichin B derivative, and preparation method and use thereof

7. 9249137 - Dicarboximide derivatives of berbamine, the preparation and use thereof

8. 9156801 - 2-substituted oleanolic acid derivative, method preparing for same, and application thereof

9. 9133207 - Tetrandrine derivatives with substituted 5-carbon, preparation method and use thereof

10. 8987288 - Heterocyclic aminoberbamine derivatives, the preparation process and use thereof

11. 8987502 - Oleanolic acid amidate derivatives, preparation methods and uses thereof

Please report any incorrect information to support@idiyas.com
idiyas.com
as of
1/2/2026
Loading…